Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18760208 | REDUCING ELEVATED INTRAOCULAR PRESSURE VIA A STIMULATION ELECTRODE ASSEMBLY | July 2024 | March 2025 | Allow | 9 | 1 | 0 | No | No |
| 18670220 | TISSUE EXTRACTION DEVICES AND METHODS | May 2024 | June 2025 | Allow | 13 | 2 | 0 | No | No |
| 18646184 | SYSTEM AND METHOD FOR ELECTROCARDIOGRAM ANALYSIS AND OPTIMIZATION OF CARDIOPULMONARY RESUSCITATION AND THERAPY DELIVERY | April 2024 | June 2025 | Allow | 13 | 1 | 0 | Yes | No |
| 18643195 | MEDICAL MONITORING DEVICE FOR HARMONIZING PHYSIOLOGICAL MEASUREMENTS | April 2024 | May 2025 | Allow | 12 | 1 | 0 | No | No |
| 18629125 | SYSTEMS AND METHODS FOR TREATING MYOCARDIAL CONDITIONS | April 2024 | December 2024 | Allow | 8 | 2 | 0 | Yes | No |
| 18618822 | Methods for Reducing the Risk of Heart Failure or Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations | March 2024 | December 2024 | Allow | 9 | 2 | 0 | No | No |
| 18439536 | SUBCUTANEOUS DEVICE | February 2024 | January 2025 | Allow | 11 | 1 | 0 | No | No |
| 18424631 | METHOD AND SYSTEM FOR ALTERING BODY MASS COMPOSITION USING GALVANIC VESTIBULAR STIMULATION | January 2024 | April 2025 | Allow | 15 | 1 | 0 | Yes | No |
| 18542883 | EJACULATION CONTROL | December 2023 | January 2025 | Allow | 13 | 1 | 0 | No | No |
| 18536344 | SYSTEMS AND METHODS OF DELIVERING THERAPY USING AN AMBULATORY MEDICAL DEVICE | December 2023 | July 2025 | Allow | 19 | 2 | 0 | No | No |
| 18388383 | IMPELLER FOR BLOOD PUMP | November 2023 | April 2025 | Allow | 17 | 1 | 0 | No | No |
| 18383575 | Intravenous / Intra-Spinal / Intra-Cavity / Intraventricular Delivery of TTFields (Tumor Treating Fields) for Treating Cancer and Metastases | October 2023 | November 2024 | Allow | 13 | 0 | 1 | Yes | No |
| 18376727 | Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations | October 2023 | June 2024 | Allow | 8 | 1 | 0 | No | No |
| 18459044 | VACUUM LOSS DETECTION DURING LASER EYE SURGERY | August 2023 | November 2024 | Allow | 14 | 1 | 0 | No | No |
| 18224638 | APPARATUS, SYSTEM AND OPERATION METHOD FOR THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION | July 2023 | December 2024 | Allow | 17 | 2 | 0 | No | No |
| 18222621 | Methods for Reducing the Risk of Strokes by Pharmacotherapy to Reduce the Number and Duration of Atrial Fibrillations | July 2023 | January 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18212844 | Heart Beat Identification and Pump Speed Synchronization | June 2023 | October 2024 | Allow | 15 | 1 | 0 | No | No |
| 18205015 | MICROWAVE ABLATION SYSTEM | June 2023 | June 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18318313 | APPARATUS AND METHODS FOR RESECTING AND/OR ABLATING AN UNDESIRED TISSUE | May 2023 | August 2024 | Allow | 16 | 1 | 0 | No | No |
| 18313444 | INTRA-CARDIAC MAPPING AND ABLATING | May 2023 | December 2024 | Allow | 19 | 2 | 0 | Yes | No |
| 18308561 | MEDICAL SYSTEM AND METHOD OF USE | April 2023 | July 2024 | Allow | 14 | 1 | 0 | No | No |
| 18080115 | PERSONALIZED HEART RHYTHM THERAPY | December 2022 | March 2025 | Allow | 27 | 1 | 1 | No | No |
| 17938595 | PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXT | October 2022 | July 2024 | Allow | 22 | 1 | 0 | No | No |
| 17951175 | SYSTEM AND METHOD FOR AN ELECTRICAL IMPLANT DEVICE WITH INCREASED PATIENT COMPLIANCE | September 2022 | May 2025 | Allow | 31 | 2 | 0 | No | No |
| 17902836 | Diagnosis of medical conditions using voice recordings and auscultation | September 2022 | September 2024 | Allow | 24 | 2 | 0 | Yes | No |
| 17897480 | SUBCUTANEOUS IMPLANTABLE DEFIBRILLATOR WITH EPICARDIAL LEAD FOR RESYNCHRONIZATION THERAPY | August 2022 | September 2024 | Abandon | 24 | 1 | 0 | No | No |
| 17894765 | INTEGRATED PROBE STRUCTURE | August 2022 | May 2025 | Allow | 33 | 2 | 1 | Yes | No |
| 17819108 | MOBILE DEFIBRILLATOR | August 2022 | December 2024 | Allow | 28 | 2 | 0 | Yes | No |
| 17813739 | ENERGY CONVERSION MONITORING DEVICES AND METHODS | July 2022 | July 2024 | Allow | 24 | 2 | 0 | No | No |
| 17812974 | SYSTEM AND METHOD FOR SENSING AND DETECTION IN AN EXTRA-CARDIOVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | July 2022 | December 2024 | Allow | 29 | 1 | 0 | Yes | No |
| 17864983 | STIMULATION PROBE ASSEMBLIES AND METHODS OF USE | July 2022 | September 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17856946 | MULTI-THRESHOLD SENSING OF CARDIAC ELECTRICAL SIGNALS IN AN EXTRACARDIOVASCULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | July 2022 | February 2025 | Allow | 31 | 1 | 0 | Yes | No |
| 17851236 | METHOD AND DEVICE FOR MANAGING PACING THERAPY BASED ON INTERVENTRICULAR SEPTAL ACTIVITY | June 2022 | April 2024 | Allow | 22 | 1 | 0 | No | No |
| 17850987 | OPHTHALMIC TREATMENT DEVICE, METHOD FOR CONTROLLING OPHTHALMIC TREATMENT DEVICE, AND FUNDUS LESION TREATMENT METHOD | June 2022 | June 2024 | Allow | 23 | 1 | 0 | No | No |
| 17838128 | LIGHT-BASED NON-INVASIVE BLOOD PRESSURE SYSTEMS AND METHODS | June 2022 | July 2024 | Allow | 26 | 1 | 1 | Yes | No |
| 17806124 | PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXT | June 2022 | August 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 17806120 | PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXT | June 2022 | July 2024 | Allow | 26 | 2 | 0 | No | No |
| 17806117 | PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXT | June 2022 | July 2024 | Allow | 25 | 2 | 0 | Yes | No |
| 17748533 | System And Method For Predicting Tissue Integrity | May 2022 | March 2025 | Allow | 34 | 2 | 1 | Yes | No |
| 17740333 | ELECTROCARDIOGRAM METHOD FOR LACTATE THRESHOLD DETECTION | May 2022 | November 2023 | Allow | 19 | 0 | 0 | No | No |
| 17720439 | SMART WRISTBAND FOR MULTIPARAMETER PHYSIOLOGICAL MONITORING | April 2022 | February 2025 | Allow | 34 | 1 | 0 | Yes | No |
| 17768329 | METHODS AND SYSTEMS FOR MODULATING CELLULAR ACTIVATION | April 2022 | May 2025 | Allow | 37 | 2 | 1 | Yes | No |
| 17717864 | IMPLANTABLE DEVICE HAVING ONE OR MORE SCREWS | April 2022 | December 2024 | Abandon | 32 | 0 | 1 | No | No |
| 17767647 | Implantable Medical Device | April 2022 | February 2024 | Allow | 22 | 4 | 0 | Yes | No |
| 17641753 | PACEMAKER DEVICE | March 2022 | July 2024 | Allow | 28 | 2 | 0 | No | No |
| 17679450 | APPARATUS AND METHOD FOR TREATMENT OF DRY EYES | February 2022 | April 2025 | Abandon | 38 | 4 | 0 | No | Yes |
| 17675903 | DEVICES AND METHODS TO MEASURE GASTRIC RESIDUAL VOLUME | February 2022 | June 2024 | Allow | 28 | 1 | 0 | No | No |
| 17675944 | Comprehensive Second-Language Acquisition System Leveraging Sleep Neuromodulation and Neuroaugmented Executive Control | February 2022 | January 2025 | Allow | 35 | 3 | 0 | No | No |
| 17669294 | DEVICE AND METHOD FOR ATRIAL TACHYARRHYTHMIA DETECTION | February 2022 | January 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17587223 | TISSUE EXTRACTION DEVICES AND METHODS | January 2022 | February 2024 | Allow | 25 | 2 | 0 | No | No |
| 17565747 | DEVICE AND METHOD FOR TREATING DRY EYES | December 2021 | March 2025 | Allow | 38 | 1 | 1 | No | No |
| 17552813 | MANAGING THERAPY DELIVERY BASED ON PHYSIOLOGICAL MARKERS | December 2021 | September 2024 | Allow | 33 | 1 | 0 | No | No |
| 17542776 | STIMULUS COIL AND PULSE GENERATOR FOR WIRELESS GLAUCOMA THERAPY | December 2021 | February 2024 | Allow | 26 | 1 | 0 | No | No |
| 17541075 | VENTRICULAR BLANKING PERIOD AFTER ATRIALLY SENSED BEATS | December 2021 | September 2024 | Allow | 33 | 1 | 0 | Yes | No |
| 17528721 | SYSTEM FOR IDENTIFYING AND REMEDIATING PATIENT WITHDRAWAL SYMPTOMS | November 2021 | October 2024 | Allow | 35 | 2 | 0 | Yes | No |
| 17607711 | SYSTEMS AND METHODS FOR QUANTITATIVE ECG HETEROGENEITY-GUIDED OPTIMIZATION OF THERAPEUTIC EFFICACY OF IMPLANTABLE CARDIAC DEVICES | October 2021 | September 2024 | Abandon | 34 | 1 | 0 | No | No |
| 17498402 | Defibrillation Through Synchronous Multisite Pacing | October 2021 | September 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17495644 | DEEP TREATMENT DRESSINGS | October 2021 | January 2025 | Abandon | 39 | 4 | 0 | No | No |
| 17493539 | GUIDING ANTI-TACHYARRHYTHMIA PACING TRAIN DESIGN AND ELECTRODE SELECTION WITH ELECTROGRAMS | October 2021 | May 2024 | Allow | 32 | 1 | 0 | Yes | No |
| 17465673 | CURRENT STEERING FOR CARDIAC PACING | September 2021 | January 2025 | Allow | 40 | 3 | 1 | Yes | No |
| 17459338 | SURGICAL TOOL FOR ROBOTIC SURGERY AND ROBOTIC SURGICAL ASSEMBLY | August 2021 | April 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17406411 | REDUCING ELECTROCARDIOGRAM ARTIFACTS DURING AND POST CPR | August 2021 | June 2024 | Allow | 34 | 2 | 0 | Yes | No |
| 17445214 | CHARGE COMPENSATION CIRCUIT FOR NEURAL STIMULATION | August 2021 | April 2024 | Allow | 32 | 1 | 0 | No | No |
| 17445215 | PULSE CURRENT GENERATION CIRCUIT | August 2021 | April 2024 | Allow | 32 | 1 | 0 | Yes | No |
| 17400648 | ADAPTIVE CALIBRATION FOR SENSOR-EQUIPPED ATHLETIC GARMENTS | August 2021 | July 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17393989 | APPARATUS AND METHOD FOR NERVE ABLATION IN THE WALL OF THE GASTOINTESTINAL TRACT | August 2021 | August 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17389047 | PERSONALIZED AVATAR RESPONSIVE TO USER PHYSICAL STATE AND CONTEXT | July 2021 | January 2024 | Allow | 29 | 2 | 0 | No | No |
| 17382217 | SYSTEMS AND METHODS OF ANALYTE MEASUREMENT ANALYSIS | July 2021 | October 2024 | Allow | 39 | 3 | 0 | Yes | No |
| 17304605 | SYSTEMS AND METHODS FOR DETECTING FAULT CONDITIONS IN ELECTROPORATION THERAPY | June 2021 | August 2024 | Allow | 37 | 2 | 0 | No | No |
| 17415303 | INTRAORAL NEUROMODULATION | June 2021 | June 2025 | Allow | 48 | 2 | 1 | Yes | No |
| 17344745 | SUBCUTANEOUS DEVICE | June 2021 | September 2023 | Allow | 28 | 2 | 0 | Yes | No |
| 17344731 | METHOD OF INJECTING SUBCUTANEOUS DEVICE | June 2021 | August 2023 | Allow | 27 | 0 | 0 | No | No |
| 17337530 | MODULATE PACING RATE TO INCREASE THE PERCENTAGE OF EFFECTIVE VENTRICULAR CAPTURE DURING ATRIAL FIBRILLATION | June 2021 | November 2023 | Allow | 29 | 2 | 0 | Yes | No |
| 17328928 | PATIENT MONITORING AND TREATMENT SYSTEMS AND METHODS | May 2021 | December 2023 | Allow | 31 | 1 | 1 | Yes | No |
| 17324705 | DEVICES, METHODS, AND SYSTEMS FOR THE TREATMENT AND/OR MONITORING OF DAMAGED TISSUE | May 2021 | February 2024 | Allow | 33 | 3 | 0 | Yes | No |
| 17324396 | MEDICAL MONITORING DEVICE FOR HARMONIZING PHYSIOLOGICAL MEASUREMENTS | May 2021 | February 2024 | Allow | 32 | 2 | 0 | Yes | No |
| 17318014 | APPARATUS FOR ENDO FISTULA LASER THERAPY | May 2021 | February 2024 | Abandon | 33 | 2 | 0 | No | No |
| 17181605 | IMPLANTABLE STIMULATING ASSEMBLY | February 2021 | August 2024 | Allow | 42 | 2 | 1 | Yes | Yes |
| 17165129 | METHODS, SYSTEM AND DEVICE FOR IMPROVING CARDIAC RESYNCHRONIZATION THERAPY (CRT) | February 2021 | October 2023 | Allow | 32 | 1 | 1 | No | No |
| 17248488 | HEALTH TRACKING DEVICE | January 2021 | June 2024 | Allow | 41 | 3 | 1 | Yes | No |
| 17129467 | NEUROSTIMULATION TITRATION UTILIZING T-WAVE ALTERNANS | December 2020 | May 2024 | Allow | 40 | 2 | 1 | Yes | No |
| 17054882 | METHOD AND DEVICE FOR PROCESSING PHYSIOLOGICAL DATA, AND STORAGE MEDIUM | November 2020 | October 2024 | Abandon | 47 | 2 | 0 | No | No |
| 17090259 | HUMAN BIOELECTRICAL SIGNAL DETECTION AND MONITORING | November 2020 | December 2023 | Allow | 37 | 1 | 0 | No | No |
| 17050702 | MULTI-SENSOR BASED HMI/AI-BASED SYSTEM FOR DIAGNOSIS AND THERAPEUTIC TREATMENT OF PATIENTS WITH NEUROLOGICAL DISEASE | October 2020 | March 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17061513 | SYSTEM AND METHOD FOR ELECTROCARDIOGRAM ANALYSIS AND OPTIMIZATION OF CARDIOPULMONARY RESUSCITATION AND THERAPY DELIVERY | October 2020 | January 2024 | Allow | 40 | 2 | 1 | Yes | No |
| 17035157 | AV NODAL STIMULATION DURING ATRIAL TACHYARRHYTHMIA TO PREVENT INAPPROPRIATE THERAPY DELIVERY | September 2020 | September 2023 | Allow | 36 | 1 | 0 | No | No |
| 17024885 | SYSTEMS AND METHODS OF DELIVERING THERAPY USING AN AMBULATORY MEDICAL DEVICE | September 2020 | September 2023 | Allow | 36 | 2 | 0 | Yes | No |
| 16957164 | ON-BED STATE MONITORING SYSTEM AND BED INCLUDING SAME | August 2020 | April 2024 | Allow | 46 | 7 | 0 | Yes | No |
| 16941085 | BRAIN STIMULATION THERAPY | July 2020 | November 2023 | Allow | 39 | 4 | 0 | Yes | No |
| 16924990 | ANALYZING ECAP SIGNALS | July 2020 | November 2023 | Allow | 41 | 4 | 0 | Yes | No |
| 16957752 | EJACULATION CONTROL | June 2020 | September 2023 | Allow | 39 | 3 | 0 | Yes | No |
| 16772883 | MULTI-LAYER STRUCTURE, SYSTEM, USE AND METHOD | June 2020 | September 2024 | Abandon | 51 | 4 | 0 | Yes | No |
| 16897171 | METHODS FOR TREATMENT OF DISEASE USING GALVANIC VESTIBULAR STIMULATION | June 2020 | October 2023 | Allow | 40 | 3 | 0 | No | Yes |
| 16767768 | STORING A SIGNAL TO A MEMORY | May 2020 | November 2023 | Allow | 42 | 3 | 0 | Yes | No |
| 16724518 | METHOD AND SOFTWARE TO DETERMINE PROBABILITY OF SLEEP/WAKE STATES AND QUALITY OF SLEEP AND WAKEFULNESS FROM AN ELECTROENCEPHALOGRAM | December 2019 | April 2024 | Abandon | 52 | 3 | 0 | No | Yes |
| 16677893 | VENA-CAVAL BLOOD PUMP | November 2019 | October 2023 | Allow | 47 | 4 | 1 | Yes | No |
| 16660212 | METHODS AND DEVICES FOR CONTROLLING ABLATION THERAPY | October 2019 | May 2023 | Allow | 43 | 3 | 0 | Yes | No |
| 16585344 | ADHESIVELY COUPLED WEARABLE MEDICAL DEVICE | September 2019 | October 2023 | Allow | 49 | 2 | 2 | Yes | No |
| 16573606 | WEARABLE CARDIAC MONITOR | September 2019 | June 2023 | Allow | 45 | 2 | 1 | Yes | No |
| 16358123 | MANUFACTURING METHOD FOR A MULTIELECTRODE SYSTEM | March 2019 | June 2024 | Allow | 60 | 6 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOLMES, REX R.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 14.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner HOLMES, REX R works in Art Unit 3796 and has examined 121 patent applications in our dataset. With an allowance rate of 87.6%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 33 months.
Examiner HOLMES, REX R's allowance rate of 87.6% places them in the 63% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by HOLMES, REX R receive 2.04 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by HOLMES, REX R is 33 months. This places the examiner in the 30% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +17.6% benefit to allowance rate for applications examined by HOLMES, REX R. This interview benefit is in the 63% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 30.8% of applications are subsequently allowed. This success rate is in the 53% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 42.4% of cases where such amendments are filed. This entry rate is in the 58% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 0.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 21% percentile among all examiners. Note: Pre-appeal conferences show limited success with this examiner compared to others. While still worth considering, be prepared to proceed with a full appeal brief if the PAC does not result in favorable action.
This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 47% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 6% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 3.3% of allowed cases (in the 84% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.7% of allowed cases (in the 81% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.